An amendment numbered 37 printed in the Congressional Record to add a provision to the bill that prohibits the use of funds from being used to approve any application for a new drug submitted by an entity that does not agree to a quarterly disclosure of the average price charged by the manufacturer for the most common dosage of the drug in each country that is a member of OECD.

openUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

By unanimous consent, the Brown (OH) amendment was withdrawn.

Records

Official amendment HAMDT 975 (106th) from United States at United States Congress. Status: By unanimous consent, the Brown (OH) amendment was withdrawn..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2001

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/106th-congress/hamdt-975
Open data entity: https://api.congress.gov/v3/amendment/106/hamdt/975
us · 106-hamdt-975 · source updated 25 February 2022